March 28, 2025

Leads:

Carol Levy – Mt. Sinai (Adult)

Emily Coppedge – Cornell (Peds)

Emily Coppedge  (Weil Cornell) Discussed Interesting Ways to Utilize HCLs Presentation

• Discussion on key takeaways, research findings, and implications for clinical practice
• Q&A with Emily Coppedge

Insurance Issues and Medication Use

• Type 2 diabetes diagnosis can be an insurance issue.
• One patient with Medicaid got approved for medication after providing data to prove improvement.
• Ozempic is used more in type 1 patients than Mounjaro.
• Mounjaro is frequently prescribed on the adult side, depending on the formulary.

Medication Usage in Pediatric Patients

• Ozempic is used in patients with type 2 diabetes.
• Tirzepatide was approved for some patients aged 16 or 17 with high BMIs.
• Off-label use was pursued due to the need for proactive intervention.

Discussions on Current QI Projects and Best Practices

• The team is having more discussions about pumps and sensors in the hospital.
• Sharing information and ideas is encouraged to see if practices are changing.

Upcoming Meetings

• Next meeting: April 25th, 2:00 PM Eastern.
• Ruth Weinstock will speak on hybrid closed loop in the elderly population.
• Rayon Lal will speak about DIY systems at the subsequent meeting.

Presentation: Understanding HCLs and Unique ways to manage patients on HCLs- Emily Coppedge

Meeting Recording: Hybrid Closed Loop Working Group-20250328_140526-Meeting Recording.mp4